Fanny Tzelepis

Title: Fanny Tzelepis: Innovator in Recombinant Bacterium Technology

Introduction

Fanny Tzelepis is a notable inventor based in Ottawa, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant bacteria for immunological applications. Her work focuses on creating innovative solutions that enhance the immune response against various pathogens.

Latest Patents

Fanny Tzelepis holds a patent for a recombinant bacterium and its uses. The invention relates to a recombinant bacterium that expresses an antigen translocated to the cytosol of a host organism. This bacterium comprises a nucleic acid encoding an antigen that utilizes the Type III secretion system. The recombinant bacterium is typically selected from intracellular pathogens that reside in the phagosome and do not induce rapid T cell activation. The translocated antigen can be a viral, bacterial, or tumor antigen. Additionally, methods for imparting immunity using this recombinant bacterium are also included in her patent.

Career Highlights

Fanny Tzelepis is affiliated with the National Research Council of Canada, where she conducts her research and development activities. Her work has been instrumental in advancing the understanding of how recombinant bacteria can be utilized to improve immune responses.

Collaborations

Fanny collaborates with esteemed colleagues, including Kevin Young and Subash Sad. Their combined expertise contributes to the innovative research being conducted at the National Research Council of Canada.

Conclusion

Fanny Tzelepis is a pioneering inventor whose work in recombinant bacterium technology holds promise for enhancing immunological responses. Her contributions to biotechnology are significant and continue to impact the field positively.